Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based survey

被引:1
|
作者
Cortinovis, Diego [1 ]
Beretta, Giordano [2 ]
Piazza, Elena [3 ]
Luchena, Giovanna [4 ]
Aglione, Stefania [5 ]
Bertolini, Alessandro [6 ]
Buzzoni, Roberto [7 ]
Cabiddu, Mary [8 ]
Carnaghi, Carlo [9 ,10 ]
Danova, Marco [11 ]
Farina, Gabriella [12 ]
Ferrari, Vittorio [13 ]
Frascaroli, Mara [14 ]
Reni, Michele [15 ]
Tansini, Giuseppe [16 ]
机构
[1] San Gerardo Hosp, Monza, Italy
[2] Humanitas Gavazzeni, Oncol Med, Bergamo, Italy
[3] L Sacco Hosp Vialba, Milan, Italy
[4] St Anna Hosp, Como, Italy
[5] Vimercate Hosp, Monza, Italy
[6] Osped Civile, Sondrio, Italy
[7] Fdn IRCCS Ist Nazl Tumori, DH & Terapia Ambulatoriale Oncol, Milan, Italy
[8] Osped Trevigliocaravaggio, Bergamo, Italy
[9] Humanitas Mater Domini, Oncol Med, Castellanza, VA, Italy
[10] Humanitas Canc Ctr, Oncoematol, Rozzano, MI, Italy
[11] Osped Civile, Vigevano, PV, Italy
[12] Fatebenefratelli Hosp, Milan, Italy
[13] Spedali Civil Brescia, I-25125 Brescia, Italy
[14] Fdn Maugeri, Pavia, Italy
[15] Hosp San Raffaele, I-20132 Milan, Italy
[16] Lodi Hosp, Lodi, MI, Italy
来源
TUMORI JOURNAL | 2013年 / 99卷 / 01期
关键词
blood transfusion; chemotherapy-induced anemia; erythropoietin; survey; ERYTHROPOIESIS-STIMULATING AGENTS; INTRAVENOUS IRON; DARBEPOETIN ALPHA; CANCER-PATIENTS; MULTICENTER; SUPPLEMENTATION; METAANALYSIS; PREVALENCE; MORTALITY; SURVIVAL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background. Anemia prevalence and incidence in chemotherapy-treated patients is high. Erythropoiesis-stimulating agents (ESAs) are frequently employed in the management of chemotherapy-induced anemia. However, other treatments such as red blood transfusion or iron supplementation are normally used. Recent international guidelines raised some concern about ESAs employment with a possible impact in chemotherapy-induced anemia management and changes in clinical practice behavior. Methods. To evaluate opinions about chemotherapy-induced anemia clinical management preference, the Associazione Italiana Oncologia Medica (ATOM) Lombardy section coordinators sent via email a 12-item questionnaire about their knowledge on CIA and usual therapeutic strategies to manage this adverse event to ATOM Lombardy onco-hematologist members. Results. From January 2011 to March 2011, 81 questionnaires were collected with an approximated share of 30%. The survey was completed mainly by oncologists (91%) aged 35-50 years (50%). Chemotherapy-induced anemia was considered to have clinical impact in changing cancer therapeutic strategy by nearly 60% of the respondents. ESAs were administered largely (80%) with concomitant iron supplementation in 52%; 38% jointly used blood transfusion as part of the therapy. Nearly 20% of those who replied correctly employed transferrin saturation levels as a marker to guide iron supplementation. Physician prescribers strictly followed the guidelines to start and stop ESAs even if 14% were negatively influenced by new ASCO recommendations. ESA biosimilars were considered future substitutes of originators in 45% of the cases. Conclusions. Chemotherapy-induced anemia was perceived as an adverse event with a mild impact on clinical practice. ESAs were largely employed, however the number of transfusions and lack of employment of markers of iron depletion suggested that adherence to guidelines could be theoretically met but with some discordances regarding the most appropriate strategies in daily clinical practice.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 50 条
  • [1] Questionnaire-based survey on chemotherapy-induced anemia
    Tanaka, Asashi
    Yoshino, Ichiro
    Makino, Shigeyoshi
    Katsumata, Noriyuki
    Takahashi, Koki
    Kuwano, Hiroyuki
    Maehara, Yoshihiko
    Nishiyama, Masahiko
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 411 - 420
  • [2] Questionnaire-based survey on chemotherapy-induced anemia
    Asashi Tanaka
    Ichiro Yoshino
    Shigeyoshi Makino
    Noriyuki Katsumata
    Koki Takahashi
    Hiroyuki Kuwano
    Yoshihiko Maehara
    Masahiko Nishiyama
    [J]. International Journal of Clinical Oncology, 2014, 19 : 411 - 420
  • [3] Usability and Acceptability of a Web-Based Program for Chemotherapy-Induced Peripheral Neuropathy
    Tofthagen, Cindy
    Kip, Kevin E.
    Passmore, Denise
    Loy, Ian
    Berry, Donna L.
    [J]. CIN-COMPUTERS INFORMATICS NURSING, 2016, 34 (07) : 322 - 329
  • [4] Usability and Acceptability of a Web-Based Program for Chemotherapy-Induced Peripheral Neuropathy
    Tofthagen, Cindy
    Loy, Ian
    Passmore, Denise
    Berrry, Donna
    [J]. PSYCHO-ONCOLOGY, 2014, 23 : 60 - 61
  • [5] Chemotherapy-induced anemia in adults: Incidence and treatment
    Groopman, JE
    Itri, LM
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (19) : 1616 - 1634
  • [6] Epoetin beta for the treatment of chemotherapy-induced anemia: an update
    Galli, Luca
    Ricci, Clara
    Egan, Colin Gerard
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 583 - 591
  • [7] Pilot Testing a Web-Based System for the Assessment and Management of Chemotherapy-Induced Peripheral Neuropathy
    Knoerl, Robert
    Dudley, William N.
    Smith, Gloria
    Bridges, Celia
    Kanzawa-Lee, Grace
    Smith, Ellen M. Lavoie
    [J]. CIN-COMPUTERS INFORMATICS NURSING, 2017, 35 (04) : 201 - 211
  • [8] Chemotherapy-induced neutropenia: The oncologist's point of view
    de Jesus Sobrevilla Calvo, Pedro
    Sobrevilla Moreno, Nora
    Ochoa Carrillo, Francisco Javier
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2016, 15 (06): : 344 - 349
  • [9] Local anaesthetics risks perception: A web-based survey
    Beckmann, Tal Sarah
    Samer, Caroline Flora
    Wozniak, Hannah
    Savoldelli, Georges Louis
    Suppan, Melanie
    [J]. HELIYON, 2024, 10 (01)
  • [10] Rapid Anaemia Control with Epoetin: Results of a Swiss Survey on Treatment of Chemotherapy-Induced Anaemia
    Popescu, Razvan
    von Rohr, Albert
    Piguet, Domenique
    Irle, Claudius
    Giger, Michael
    Brunner, Ralf
    Ahnesorg, Peter
    Zappa, Francesco
    [J]. ACTA HAEMATOLOGICA, 2010, 123 (02) : 129 - 134